South Cameron High Sbhc Clinic/Center - Student Health Medicare: Not Enrolled in Medicare Practice Location: 753 Oak Grove Hwy, Grand Chenier, LA 70643 Phone: 337-542-4441 Fax: 337-542-4588 |
News Archive
Autism Speaks, the world's leading autism science and advocacy organization, today announced the awarding of new research grants totaling nearly $5 million. "Autism Speaks is committed to continuing our research which has tremendous potential to increase our understanding of autism and addressing the needs of individuals with autism," said Autism Speaks Co-founder Bob Wright, "and we are grateful to the donors who make this research possible."
The Food and Drug Administration (FDA) has cleared for marketing a test that determines the likelihood of breast cancer returning within five to 10 years after a woman's initial cancer. It is the first cleared molecular test that profiles genetic activity.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for the subcutaneous formulation of ORENCIA® (abatacept), a treatment for adult patients with moderate to severe rheumatoid arthritis (RA) administered through an injection into the skin. Bristol-Myers Squibb submitted the sBLA to the FDA for the subcutaneous formulation of ORENCIA and received confirmation of its receipt on October 4, 2010.
Capsules of insulin produced in genetically modified lettuce could hold the key to restoring the body's ability to produce insulin and help millions of Americans who suffer from insulin-dependent diabetes, according to University of Central Florida biomedical researchers.
› Verified 1 days ago